MDL No. 09-2081 (E.D. Pa.)
SRK is currently serving as sole Interim Lead Class Counsel in In re Blood Reagents Antitrust Litigation, MDL 09-2081 (E.D. Pa.), a nation-wide class action consisting of blood agent purchasers, including but not limited to hospitals and blood banks, alleging price-fixing in the market for blood reagents, which are used for typing and screening blood. In August 2010, Judge Jan DuBois denied defendants’ motion to dismiss the consolidated amended complaint. SRK filed a detailed motion for class certification on behalf of a proposed class of direct purchasers of blood reagents, featuring over 140 exhibits, in September 2011. On August 22, 2012, Judge DuBois certified the class. After Defendant Ortho-Clinical Diagnostics’ appeal, the class scored another victory as Judge DuBois again certified the class on October 19, 2015. Ortho Clinical Diagnostics filed a Motion for Summary Judgment on July 15, 2016, and oral argument was held before Judge DuBois on January 20, 2017.
On January 11, 2012, SRK and defendant Immucor, Inc. entered into a settlement agreement which required Immucor to pay $22 million and to provide substantial cooperation in Plaintiffs’ continuing litigation against Ortho-Clinical Diagnostics, Inc.